Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | RAB9A | P51151 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | S100A4 | P26447 | 3/20 | 0.74 |
| ▸ | PTPRC | P08575 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | APAF1 | O14727 | 1/20 | 0.74 |
| ▸ | TDP2 | O95551 | 1/20 | 0.74 |
| ▸ | NSD2 | O96028 | 1/20 | 0.74 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | CTSL | P07711 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30350052 | 1.00 | NPC1 (0.77) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL6938108 | 0.97 | NPC1 (0.74) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL9019017 | 0.95 | NPC1 (0.78) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL31087632 | 0.95 | NPC1 (0.78) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL3135129 | 0.94 | NPC1 (0.86) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5551699 | 0.94 | S100A4 (0.82) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL28005394 | 0.92 | NPC1 (0.82) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL30482647 | 0.91 | NPC1 (0.95) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL760965 | 0.91 | NPC1 (0.95) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL31615519 | 0.91 | NPC1 (0.95) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775947-A | Adhesive, and preparation method and application thereof | 深圳市研一新材料有限责任公司 | 2025-04-08 | — | — | CN | claimed |
| US-20240409495-A1 | PROCESS FOR THE PREPARATION OF 2,7-DIHYDROXY-9-FLUORENONE USEFUL FOR THE SYNTHESIS OF TILORONE AND ITS SALTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-12-12 | — | — | US | claimed |
| CN-118834119-A | Method for synthesizing bisphenol compound by catalysis of supported ionic liquid | 郑州中科新兴产业技术研究院 | 2024-10-25 | — | — | CN | claimed |
| CN-116355434-B | Method for preparing direct dye by replacing benzidine | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2024-07-09 | — | — | CN | claimed |
| CN-118175999-A | Process for the preparation of 2, 7-dihydroxy-9-fluorenone useful for the synthesis of telulone and its salts | 科学与工业研究委员会 | 2024-06-11 | — | — | CN | claimed |
| CN-116355434-A | Method for preparing direct dye by replacing benzidine | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2023-06-30 | — | — | CN | claimed |
| WO-2023067624-A1 | A PROCESS FOR THE PREPARATION OF 2,7-DIHYDROXY-9-FLUORENONE USEFUL FOR THE SYNTHESIS OF TILORONE AND ITS SALTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-04-27 | — | — | WO | claimed |
| EP-1799791-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-01-13 | — | — | EP | claimed |
| CN-103558742-A | Fine developer for large-breadth development and preparation method thereof | TIANJIN INST OF REPROGRAPHIC TECHNOLOGY | 2014-02-05 | — | — | CN | claimed |
| CN-101040028-B | Photocrosslinkable materials | ROLIC AG | 2012-03-28 | — | — | CN | claimed |
| WO-2004065524-A1 | ANISOTROPIC FILM MANUFACTURING | NITTO DENKO CORPORATION (JP) | 2004-08-05 | — | — | WO | claimed |
| WO-2004064112-A2 | BACKLIGHT POLAR ORGANIC LIGHT-EMITTING DEVICE | NITTO DENKO CORPORATION (JP) | 2004-07-29 | — | — | WO | claimed |
| US-20040142183-A1 | Anisotropic film manufacturing | INSOLVENCY SERVICES GROUP, INC. | 2004-07-22 | — | — | US | claimed |
| EP-0577245-B1 | Photogenerating azo pigments | XEROX CORP (US) | 1998-12-02 | — | — | EP | claimed |
| WO-1994025649-A1 | MODIFIED POLYIMIDE FIBRES, PROCESS FOR PRODUCING THE SAME AND THEIR USES | PION AG (CH) | 1994-11-10 | — | — | WO | claimed |
| US-5360840-A | MIXTURE OF A POLYEPOXIDE AND A CRYSTALLINE AROMATIC DIAMINE CURING AGENT | HERCULES INCORPORATED (US) | 1994-11-01 | — | — | US | claimed |
| EP-0604909-A2 | Epoxy resin compositions with improved storage stability | HERCULES INCORPORATED (US) | 1994-07-06 | — | — | EP | claimed |
| US-5281503-A | Multilayer element with disazo pigments and charge generating layer | XEROX CORPORATION (US) | 1994-01-25 | — | — | US | claimed |
| EP-0577245-A1 | Photogenerating azo pigments | XEROX CORPORATION (US) | 1994-01-05 | — | — | EP | claimed |
| US-5175258-A | Processes for the preparation of bisazo photogenerating pigments using an annealing step | XEROX CORPORATION (US) | 1992-12-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409495-A1 | PROCESS FOR THE PREPARATION OF 2,7-DIHYDROXY-9-FLUORENONE USEFUL FOR THE SYNTHESIS OF TILORONE AND ITS SALTS | TALDO1, TKFC, DHCR7 | NPC1 2166/4885ALDH1A1 3183/4885RAB9A 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.